Beth Kliethermes
No ORCID on file
· 1 paper in corpus
· active 2011
Study types
- article 1
Frequent coauthors
article
2011
BACKGROUND: In preclinical studies, müllerian inhibiting substance (MIS) has a protective affect against breast cancer. Our objective was to determine whether serum MIS concentrations were associated with cancerous or precancerous lesions. …